Summary of CCLGP1160 Immunofluorescence Quantitative Analyzer
Product Overview
CCLGP1160 is a quantitative immunofluorescence point‑of‑care analyzer, supporting a broad menu of biomarkers for reproductive‑fertility, oncology, infectious diseases, rheumatism, metabolism and other clinical fields. Many test cartridges obtain NMPA and CE certifications.
Specimen & General information
‑ Acceptable samples: serum / plasma / whole blood, stool, nasal swabs. Sample volume mainly 10‑100 μL (stool:10‑50 mg).
‑ Reaction time: 10‑15 minutes for different items; operating‑environment relative humidity ≤70%.
Test Menu
- Reproductive & Fertility markers
LH, FSH, AMH, Testosterone, Estradiol. Used for PCOS, infertility, gonadal‑function and ovarian‑reserve assessment. - Tumor Markers
tPSA, fPSA (prostate cancer); AFP (liver cancer); CEA (general malignant‑tumor screening); CA125 (ovarian cancer); CA19‑9 (pancreatic cancer); CA15‑3 (breast cancer); PGI/PGII (atrophic gastritis & gastric‑lesion risk). - Infectious Disease panel
Anti‑HCV (hepatitis‑C), Anti‑TP (syphilis), Anti‑HIV (AIDS), HBsAg / Anti‑HBs (hepatitis‑B); SARS‑CoV‑2 Antigen; H. pylori antigen & antibody; Influenza A/B, RSV‑Influenza A/B combo; Dengue NS1 Ag, Dengue IgM/IgG. - Specific‑Protein & Rheumatism
RF, ASO, Anti‑CCP for diagnosis of rheumatoid arthritis and streptococcal‑related diseases. - Metabolic & Other markers
‑ Osteocalcin: osteoporosis evaluation
‑ Cortisol: adrenal‑cortex‑function test
‑ Total IgE: allergic‑disorder detection
‑ Ferritin: for anaemia and tumour‑related assessment
no comments